Evidence map›Paper›PMID 38187255›Full record

ArticleHeliyon2024

Abraham Ehinomhen Ubhenin, Adedotun A Adefolalu, Kelly Oriakhi, Fatima Adis Adamude, Emeka John Dingwoke, Joshua Onyeka Ikebuiro, Benjamin Comfort Chiwendu, Mabruqah Liman Muhammad, Kingsley Omage

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Abraham Ehinomhen UbheninDepartment of Biochemistry, Faculty of Medical Sciences, Federal University Lafia, Nasarawa State, Nigeria.
Adedotun A AdefolaluDepartment of Biochemistry, Faculty of Medical Sciences, Federal University Lafia, Nasarawa State, Nigeria.
Kelly OriakhiDepartment of Medical Biochemistry, Faculty of Medical Sciences, University of Benin, Benin City, Nigeria.
Fatima Adis AdamudeDepartment of Biochemistry, Faculty of Medical Sciences, Federal University Lafia, Nasarawa State, Nigeria.
Emeka John DingwokeDepartment of Tropical Diseases, UNESCO-International Center for Biotechnology, University of Nigeria, Nsukka, Enugu State, Nigeria.
Joshua Onyeka IkebuiroDepartment of Biochemistry, Faculty of Medical Sciences, Federal University Lafia, Nasarawa State, Nigeria.
Benjamin Comfort ChiwenduDepartment of Biochemistry, Faculty of Medical Sciences, Federal University Lafia, Nasarawa State, Nigeria.
Mabruqah Liman MuhammadDepartment of Biochemistry, Faculty of Medical Sciences, Federal University Lafia, Nasarawa State, Nigeria.
Kingsley OmageDivision of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, Portland, United States.
Federal University Lafia · NGOregon Health & Science University · USUniversity of Benin · NGUniversity of Nigeria · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: This study is aimed at evaluating the anticancer effect of the aqueous extract of Methods: Tumors were induced via a single intraperitoneal injection of DMBA (dissolved in olive oil) at a dose of 80 mg/kg body weight to the test rats and allowed to develop for about four months. They were treated with cyclophosphamide and an aqueous extract of Results: The result revealed that DMBA is associated with a significant ( Conclusion: Our findings show that

Indexed as

Antigen 125Breast cancerCaesalpinia pulcherrimaDMBAHerbal anticancer agent

Identifiers

PMID38187255
PMCPMC10770447
OpenAlexW4389328201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.